A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)

NCT03168334 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

801

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: IDP-123 Lotion
DRUG: IDP-123 Vehicle Lotion

Sponsor

Bausch Health Americas, Inc.